Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford Progeria Syndrome
S.-I. Murtada, N. Mikush, M. Wang, P. Ren, Y. Kawamura, A. B. Ramachandra, D. T. Braddock, G. Tellides, L. B. Gordon, J. D. Humphrey
Lonafarnib improves cardiovascular function and survival in a progeria mouse model by reducing pulse wave velocity and enhancing left ventricular diastolic function.
bioRxiv · Dec 17, 2021Pathology